Telehealth patients in our study were more satisfied with their medication abortion experience, including the privacy and timeliness of care, than those receiving medication abortion in person. This should be an option for all seeking abortion care.
🔗: https://t.co/yqMwt81cSw
Telehealth medication abortion is safe, effective, and can expand access to care for many. Our recent research also found that telehealth patients reported even higher satisfaction with timeliness and privacy compared to in-person patients.
Read more: https://t.co/W8CueSz0JX
Losing access to mifepristone via mail & pharmacies would harm patients nationwide.
@UCLAReproPolicy & ANSIRH submitted a brief signed by hundreds of researchers urging SCOTUS to follow science & refrain from restricting mifepristone. https://t.co/6T85dQRnVz
We’re happy to support all reproductive health decisions, it’s up to you - NOT the government. All patients at the mobile health clinic will get a free hot dog coupon on us 🌭
We compared patients who got abortion medications in the mail using telehealth with those who came into clinics in-person. We didn't find a difference in the abortion outcomes, and there were very few adverse events. Telehealth abortion is effective and safe!
Medication abortion following no-test telehealth screening and mailing of medications was associated with similar rates of abortion completion compared with in-person care, finds this prospective, observational study. https://t.co/TGHTCwtEvG
As leaders in reproductive health, @ANSIRH & @UCSF_ObGynRS were proud to host @SecBecerra to learn about abortion research, training & clinical care. From Turnaway Study to Care Post-Roe, UCSF researchers document the harms of restricting abortion access for patients & providers.
We asked people who'd had a medication abortion why they'd be interested in being able to access the medications in advance of pregnancy or OTC. They felt it could make the experience more private, more convenient, and less burdensome (ie. less travel and fewer appointments):
Obtaining abortion pills in advance of pregnancy or OTC may be preferable for people who have experience with medication abortion.
Our findings show convenience, privacy, and avoiding burdens related to hostile policy environments are key reasons. https://t.co/twy8FHGyQz
There's a lot going on this week! This is a helpful thread in thinking through how reverting to the pre-2016 restrictions will hinder access. The REMS has always been a huge barrier:
Pharmacies will not stock abortion medications by default, even in states where abortion is legal or protected. There will need to be a push for local and the large chains to become certified to provide mifepristone!!
Pharmacists who want to learn more about medication abortion and their role in expanding access can take our 1-hour course for CPE credit:
https://t.co/Tc1UKI0dVB
Are you a pharmacist interested in learning about medication abortion? We're offering a NEW 1 hour, online course (for CPE credit) that provides an overview of medication abortion and reviews current and future roles for pharmacists in its provision: https://t.co/OMsnimWa9H
We also talked to pharmacists who were supportive of dispensing mifepristone (the drug used in medication abortions), with the necessary training.
https://t.co/lRi3u7ac33
Are you someone with data analysis skills who is angry about #abortion rights in the U.S.?
Come work with us at @ANSIRH and help strengthen the evidence-base for proactive abortion policies.
Please share widely!
https://t.co/i97sdC7YI8
Lots of folks jumping into the conversation about abortion this week. If you're looking for accurate information, the research group I work for, @ANSIRH, is a great resource:
Hi 👋 We’re a research program at @UCSF that studies reproductive health, rights, and access.
There is a lot of misinformation cropping up about abortion access right now. Follow us to get the facts.
If you’re already with us, hit RT so we can spread some science 🤓